Deep Track Capital, LP

13D and 13G Filings

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer	Symbol	CUSIP	% of Class	Shares	Form	Filed
JATT III Acquisition Corp 13G G5080G109		G5080G109	5.8%	450,000	13G	9/2/2026 Event 8/26/2026
Deep Track Capital, LP			5.8%	450,000
Deep Track Biotechnology Master Fund, Ltd.			4.4%	341,955
David Kroin			5.8%	450,000
Deep Track Special Opportunities Fund, LP.			1.4%	108,045
Nurix Therapeutics, Inc. 13G/A Amendment 3 NRIX · 67080M103	NRIX	67080M103	7.5%	7,736,455	13G/A Amendment 3	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			7.5%	7,736,455
Deep Track Biotechnology Master Fund, Ltd.			7.5%	7,736,455
David Kroin			7.5%	7,736,455
X4 Pharmaceuticals, Inc. 13G/A Amendment 1 XFOR · 98420X202	XFOR	98420X202	8.3%	8,040,894	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			8.3%	8,040,894
Deep Track Biotechnology Master Fund, Ltd.			7.2%	6,923,680
David Kroin			8.3%	8,040,894
Deep Track Special Opportunities Fund, LP.			1.2%	1,117,214
Viridian Therapeutics, Inc. 13G/A Amendment 1 VRDN · 92790C104	VRDN	92790C104	3.3%	3,592,740	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			3.3%	3,592,740
Deep Track Biotechnology Master Fund, Ltd.			3.3%	3,592,740
David Kroin			3.3%	3,592,740
Personalis, Inc. 13G/A Amendment 1 PSNL · 71535D106	PSNL	71535D106	3.8%	4,000,000	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			3.8%	4,000,000
Deep Track Biotechnology Master Fund, Ltd.			3.8%	4,000,000
David Kroin			3.8%	4,000,000
MoonLake Immunotherapeutics 13G/A Amendment 1 MLTX · 61559X104	MLTX	61559X104	9.7%	7,999,025	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			9.7%	7,999,025
Deep Track Biotechnology Master Fund, Ltd.			9.7%	7,999,025
David Kroin			9.7%	7,999,025
MBX Biosciences, Inc. 13G/A Amendment 2 MBX · 55287L101	MBX	55287L101	3.6%	1,732,569	13G/A Amendment 2	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			3.6%	1,732,569
Deep Track Biotechnology Master Fund, Ltd.			3.6%	1,732,569
David Kroin			3.6%	1,732,569
Immunovant, Inc. 13G/A Amendment 1 IMVT · 45258J102	IMVT	45258J102	4.6%	9,341,151	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			4.6%	9,341,151
Deep Track Biotechnology Master Fund, Ltd.			4.6%	9,341,151
David Kroin			4.6%	9,341,151
Enanta Pharmaceuticals, Inc. 13G/A Amendment 2 ENTA · 29251M106	ENTA	29251M106	4.97%	1,444,167	13G/A Amendment 2	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			4.97%	1,444,167
Deep Track Biotechnology Master Fund, Ltd.			4.97%	1,444,167
David Kroin			4.97%	1,444,167
enGene Therapeutics Inc. 13G/A Amendment 1 ENGN · 29286X101	ENGN	29286X101	0%	0	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Avalo Therapeutics, Inc. 13G/A Amendment 1 AVTX · 05338F306	AVTX	05338F306	6.9%	3,610,000	13G/A Amendment 1	8/14/2026 Event 6/30/2026
Deep Track Capital, LP			6.9%	3,610,000
Deep Track Biotechnology Master Fund, Ltd.			6.9%	3,610,000
David Kroin			6.9%	3,610,000
Latigo Biotherapeutics, Inc. 13G LTGO · 517954103	LTGO	517954103	7.0%	4,446,656	13G	8/13/2026 Event 8/7/2026
Deep Track Capital, LP			7.0%	4,446,656
Deep Track Biotechnology Master Fund, Ltd.			7.0%	4,446,656
David Kroin			7.0%	4,446,656
Attovia Therapeutics, Inc. 13G ATTO · 04987L102	ATTO	04987L102	7.5%	3,207,138	13G	8/12/2026 Event 8/5/2026
Deep Track Capital, LP			7.5%	3,207,138
Deep Track Biotechnology Master Fund, Ltd.			7.5%	3,207,138
David Kroin			7.5%	3,207,138
Obsidian Therapeutics, Inc. 13G OBX · 67448A106	OBX	67448A106	5.4%	3,315,605	13G	8/11/2026 Event 8/4/2026
Deep Track Capital, LP			5.4%	3,315,605
Deep Track Biotechnology Master Fund, Ltd.			5.1%	3,122,864
David Kroin			5.4%	3,315,605
Deep Track Special Opportunities Fund, LP.			0.3%	192,741
Shattuck Labs, Inc. 13G STTK · 82024L103	STTK	82024L103	5.2%	5,000,033	13G	6/17/2026 Event 6/10/2026
Deep Track Capital, LP			5.2%	5,000,033
Deep Track Biotechnology Master Fund, Ltd.			5.2%	5,000,033
David Kroin			5.2%	5,000,033
Avalo Therapeutics, Inc. 13G AVTX · 05338F306	AVTX	05338F306	5.8%	3,055,027	13G	5/29/2026 Event 5/22/2026
Deep Track Capital, LP			5.8%	3,055,027
Deep Track Biotechnology Master Fund, Ltd.			5.8%	3,055,027
David Kroin			5.8%	3,055,027
Definium Therapeutics, Inc. 13G/A Amendment 4 DFTX · 24477V105	DFTX	24477V105	3.0%	3,000,000	13G/A Amendment 4	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			3.0%	3,000,000
Deep Track Biotechnology Master Fund, Ltd.			3.0%	3,000,000
David Kroin			3.0%	3,000,000
Tarsus Pharmaceuticals, Inc. 13G/A Amendment 2 TARS · 87650L103	TARS	87650L103	8.5%	3,600,000	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			8.5%	3,600,000
Deep Track Biotechnology Master Fund, Ltd.			8.5%	3,600,000
David Kroin			8.5%	3,600,000
Ocular Therapeutix, Inc 13G/A Amendment 1 OCUL · 67576A100	OCUL	67576A100	9.5%	20,850,000	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			9.5%	20,850,000
Deep Track Biotechnology Master Fund, Ltd.			9.5%	20,850,000
David Kroin			9.5%	20,850,000
Nurix Therapeutics, Inc. 13G/A Amendment 2 NRIX · 67080M103	NRIX	67080M103	6.2%	6,345,244	13G/A Amendment 2	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			6.2%	6,345,244
Deep Track Biotechnology Master Fund, Ltd.			6.2%	6,345,244
David Kroin			6.2%	6,345,244
Inventiva S.A. 13G/A Amendment 1 IVA · 46124U107	IVA	46124U107	3.8%	7,800,465	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			3.8%	7,800,465
Deep Track Biotechnology Master Fund, Ltd.			3.8%	7,800,465
David Kroin			3.8%	7,800,465
Geron Corp 13G/A Amendment 3 GERN · 374163103	GERN	374163103	4.95%	31,720,278	13G/A Amendment 3	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			4.95%	31,720,278
Deep Track Biotechnology Master Fund, Ltd.			4.95%	31,720,278
David Kroin			4.95%	31,720,278
CorMedix Inc. 13G/A Amendment 1 CRMD · 21900C308	CRMD	21900C308	7.9%	6,274,076	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			7.9%	6,274,076
Deep Track Biotechnology Master Fund, Ltd.			7.9%	6,274,076
David Kroin			7.9%	6,274,076
Bicara Therapeutics Inc. 13G/A Amendment 1 BCAX · 055477103	BCAX	055477103	6.2%	4,062,500	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			6.2%	4,062,500
Deep Track Biotechnology Master Fund, Ltd.			6.2%	4,062,500
David Kroin			6.2%	4,062,500
Apellis Pharmaceuticals, Inc. 13G/A Amendment 1 APLS · 03753U106	APLS	03753U106	3.6%	4,532,374	13G/A Amendment 1	5/15/2026 Event 3/31/2026
Deep Track Capital, LP			3.6%	4,532,374
Deep Track Biotechnology Master Fund, Ltd.			3.6%	4,532,374
David Kroin			3.6%	4,532,374
Personalis, Inc. 13G PSNL · 71535D106	PSNL	71535D106	5.5%	5,760,627	13G	5/12/2026 Event 5/5/2026
Deep Track Capital, LP			5.5%	5,760,627
Deep Track Biotechnology Master Fund, Ltd.			5.5%	5,760,627
David Kroin			5.5%	5,760,627
Hemab Therapeutics Holdings, Inc. 13G COAG · 423494103	COAG	423494103	8.2%	3,600,996	13G	5/8/2026 Event 5/1/2026
Deep Track Capital, LP			8.2%	3,600,996
Deep Track Biotechnology Master Fund, Ltd.			6.8%	2,981,198
David Kroin			8.2%	3,600,996
Deep Track Special Opportunities Fund, LP.			1.4%	619,798
Viridian Therapeutics, Inc. 13G VRDN · 92790C104	VRDN	92790C104	5.3%	5,417,660	13G	5/8/2026 Event 5/1/2026
Deep Track Capital, LP			5.3%	5,417,660
Deep Track Biotechnology Master Fund, Ltd.			5.3%	5,417,660
David Kroin			5.3%	5,417,660
Altimmune, Inc. 13G ALT · 02155H200	ALT	02155H200	10.0%	19,417,221	13G	4/30/2026 Event 4/23/2026
Deep Track Capital, LP			10.0%	19,417,221
Deep Track Biotechnology Master Fund, Ltd.			8.7%	16,828,258
David Kroin			10.0%	19,417,221
Deep Track Special Opportunities Fund, LP.			1.3%	2,588,963
Alumis Inc. 13G ALMS · 022307102	ALMS	022307102	6.0%	7,362,035	13G	4/7/2026 Event 3/30/2026
Deep Track Capital, LP			6.0%	7,362,035
Deep Track Biotechnology Master Fund, Ltd.			6.0%	7,362,035
David Kroin			6.0%	7,362,035
Aclaris Therapeutics, Inc. 13G ACRS · 00461U105	ACRS	00461U105	7.0%	9,345,000	13G	3/17/2026 Event 3/9/2026
Deep Track Capital, LP			7.0%	9,345,000
Deep Track Biotechnology Master Fund, Ltd.			7.0%	9,345,000
David Kroin			7.0%	9,345,000
Vera Therapeutics, Inc. 13G VERA · 92337R101	VERA	92337R101	5.5%	3,921,362	13G	3/11/2026 Event 3/4/2026
Deep Track Capital, LP			5.5%	3,921,362
Deep Track Biotechnology Master Fund, Ltd.			5.5%	3,921,362
David Kroin			5.5%	3,921,362
Immunic, Inc. 13G IMUX · 4525EP101	IMUX	4525EP101	8.7%	11,454,000	13G	3/4/2026 Event 2/17/2026
Deep Track Capital, LP			8.7%	11,454,000
Deep Track Biotechnology Master Fund, Ltd.			6.8%	8,953,630
David Kroin			8.7%	11,454,000
Deep Track Special Opportunities Fund, LP.			1.9%	2,500,370
Viridian Therapeutics, Inc. 13G/A Amendment 3 VRDN · 92790C104	VRDN	92790C104	2.7%	2,524,833	13G/A Amendment 3	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			2.7%	2,524,833
Deep Track Biotechnology Master Fund, Ltd.			2.7%	2,524,833
David Kroin			2.7%	2,524,833
Terns Pharmaceuticals, Inc. 13G/A Amendment 4 TERN · 880881107	TERN	880881107	3.0%	3,150,000	13G/A Amendment 4	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			3.0%	3,150,000
Deep Track Biotechnology Master Fund, Ltd.			3.0%	3,150,000
David Kroin			3.0%	3,150,000
RAPT Therapeutics, Inc. 13G/A Amendment 1 RAPT · 75382E208	RAPT	75382E208	0.4%	110,448	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			0.4%	110,448
Deep Track Biotechnology Master Fund, Ltd.			0.4%	110,448
David Kroin			0.4%	110,448
Palisade Bio, Inc. 13G/A Amendment 1 PALI · 696389402	PALI	696389402	0%	0	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Deep Track Special Opportunities Fund, LP.			0%	0
Oruka Therapeutics, Inc. 13G/A Amendment 1 ORKA · 687604108	ORKA	687604108	4.5%	2,161,510	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			4.5%	2,161,510
Deep Track Biotechnology Master Fund, Ltd.			3.9%	1,899,455
David Kroin			4.5%	2,161,510
Deep Track Special Opportunities Fund, LP.			0.5%	262,055
Olema Pharmaceuticals, Inc. 13G/A Amendment 3 OLMA · 68062P106	OLMA	68062P106	0%	0	13G/A Amendment 3	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Jade Biosciences, Inc. 13G/A Amendment 2 JBIO · 008064206	JBIO	008064206	0%	0	13G/A Amendment 2	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Imagenebio, Inc. 13G/A Amendment 1 IMA · 45175G207	IMA	45175G207	0%	0	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Cybin Inc. 13G/A Amendment 1 HELP · 23256X407	HELP	23256X407	4.7%	2,391,505	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			4.7%	2,391,505
Deep Track Biotechnology Master Fund, Ltd.			4.7%	2,391,505
David Kroin			4.7%	2,391,505
Structure Therapeutics Inc. 13G/A Amendment 4 GPCR · 86366E106	GPCR	86366E106	6.0%	12,335,346	13G/A Amendment 4	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			6.0%	12,335,346
Deep Track Biotechnology Master Fund, Ltd.			6.0%	12,335,346
David Kroin			6.0%	12,335,346
Geron Corp 13G/A Amendment 2 GERN · 374163103	GERN	374163103	5.1%	32,511,271	13G/A Amendment 2	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			5.1%	32,511,271
Deep Track Biotechnology Master Fund, Ltd.			5.1%	32,511,271
David Kroin			5.1%	32,511,271
89bio, Inc. 13G/A Amendment 3 ETNB · 282559103	ETNB	282559103	0%	0	13G/A Amendment 3	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Enanta Pharmaceuticals Inc 13G/A Amendment 1 ENTA · 29251M106	ENTA	29251M106	6.8%	1,956,867	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			6.8%	1,956,867
Deep Track Biotechnology Master Fund, Ltd.			6.8%	1,956,867
David Kroin			6.8%	1,956,867
Definium Therapeutics, Inc. 13G/A Amendment 3 DFTX · 24477V105	DFTX	24477V105	5.5%	5,676,540	13G/A Amendment 3	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			5.5%	5,676,540
Deep Track Biotechnology Master Fund, Ltd.			5.5%	5,676,540
David Kroin			5.5%	5,676,540
Akero Therapeutics, Inc. 13G/A Amendment 1 AKRO · 00973Y108	AKRO	00973Y108	0%	0	13G/A Amendment 1	2/13/2026 Event 12/31/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Bicara Therapeutics Inc. 13G BCAX · 055477103	BCAX	055477103	5.0%	2,750,000	13G	2/12/2026 Event 2/5/2026
Deep Track Capital, LP			5.0%	2,750,000
Deep Track Biotechnology Master Fund, Ltd.			5.0%	2,750,000
David Kroin			5.0%	2,750,000
Dynavax Technologies Corporation 13G/A Amendment 3 DVAX · 268158201	DVAX	268158201	0%	0	13G/A Amendment 3	2/11/2026 Event 2/10/2026
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
LB Pharmaceuticals Inc 13D/A Amendment 1 LBRX · 50180M108	LBRX	50180M108	11.7%	3,352,804	13D/A Amendment 1	2/10/2026 Event 2/6/2025
Deep Track Biotechnology Master Fund, Ltd.			9.4%	2,686,138
Deep Track Special Opportunities Fund, LP			2.3%	666,666
Deep Track Capital, LP			11.7%	3,352,804
David Kroin			11.7%	3,352,804
Ocular Therapeutix, Inc 13G OCUL · 67576A100	OCUL	67576A100	5.1%	11,234,132	13G	2/10/2026 Event 2/5/2026
Deep Track Capital, LP			5.1%	11,234,132
Deep Track Biotechnology Master Fund, Ltd.			5.1%	11,234,132
David Kroin			5.1%	11,234,132
Ocular Therapeutix, Inc 13G/A Amendment 3 OCUL · 67576A100	OCUL	67576A100	4.3%	9,234,132	13G/A Amendment 3	2/10/2026 Event 12/31/2025
Deep Track Capital, LP			4.3%	9,234,132
Deep Track Biotechnology Master Fund, Ltd.			4.3%	9,234,132
David Kroin			4.3%	9,234,132
ProMIS Neurosciences Inc. 13G PMN · 74346M505	PMN	74346M505	10.0%	902,561	13G	2/6/2026 Event 1/30/2026
Deep Track Capital, LP			10.0%	902,561
Deep Track Biotechnology Master Fund, Ltd.			7.8%	703,457
David Kroin			10.0%	902,561
Deep Track Special Opportunities Fund, LP.			2.2%	199,104
Inventiva S.A. 13G IVA · 46124U107	IVA	46124U107	6.1%	11,668,983	13G	1/30/2026 Event 1/23/2026
Deep Track Capital, LP			6.1%	11,668,983
Deep Track Biotechnology Master Fund, Ltd.			6.1%	11,668,983
David Kroin			6.1%	11,668,983
Century Therapeutics, Inc. 13G IPSC · 15673T100	IPSC	15673T100	7.3%	13,486,400	13G	1/15/2026 Event 1/8/2026
Deep Track Capital, LP			7.3%	13,486,400
Deep Track Biotechnology Master Fund, Ltd.			5.8%	10,609,008
David Kroin			7.3%	13,486,400
Deep Track Special Opportunities Fund, LP.			1.6%	2,877,392
CorMedix Inc. 13G CRMD · 21900C308	CRMD	21900C308	6.3%	4,955,487	13G	12/1/2025 Event 11/21/2025
Deep Track Capital, LP			6.3%	4,955,487
Deep Track Biotechnology Master Fund, Ltd.			6.3%	4,955,487
David Kroin			6.3%	4,955,487
Verastem, Inc. 13G VSTM · 92337C203	VSTM	92337C203	10.0%	7,719,390	13G	11/21/2025 Event 11/14/2025
Deep Track Capital, LP			10.0%	7,719,390
Deep Track Biotechnology Master Fund, Ltd.			10.0%	7,719,390
David Kroin			10.0%	7,719,390
enGene Holdings Inc. 13G ENGN · 29286M105	ENGN	29286M105	6.7%	4,317,332	13G	11/18/2025 Event 11/11/2025
Deep Track Capital, LP			6.7%	4,317,332
Deep Track Biotechnology Master Fund, Ltd.			6.7%	4,317,332
David Kroin			6.7%	4,317,332
Zura Bio Ltd 13G/A Amendment 4 ZURA · G9TY5A101	ZURA	G9TY5A101	0.4%	259,014	13G/A Amendment 4	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			0.4%	259,014
Deep Track Biotechnology Master Fund, Ltd.			0.4%	259,014
David Kroin			0.4%	259,014
Tectonic Therapeutic, Inc. 13G/A Amendment 1 TECX · 878972108	TECX	878972108	0%	0	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Tarsus Pharmaceuticals, Inc. 13G/A Amendment 1 TARS · 87650L103	TARS	87650L103	7.1%	3,000,000	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			7.1%	3,000,000
Deep Track Biotechnology Master Fund, Ltd.			7.1%	3,000,000
David Kroin			7.1%	3,000,000
Protagonist Therapeutics, Inc 13G/A Amendment 1 PTGX · 74366E102	PTGX	74366E102	2.8%	1,715,691	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			2.8%	1,715,691
Deep Track Biotechnology Master Fund, Ltd.			2.8%	1,715,691
David Kroin			2.8%	1,715,691
Pliant Therapeutics, Inc. 13G/A Amendment 3 PLRX · 729139105	PLRX	729139105	0%	0	13G/A Amendment 3	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Ocular Therapeutix, Inc 13G/A Amendment 2 OCUL · 67576A100	OCUL	67576A100	6.2%	13,095,855	13G/A Amendment 2	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			6.2%	13,095,855
Deep Track Biotechnology Master Fund, Ltd.			6.2%	13,095,855
David Kroin			6.2%	13,095,855
Mind Medicine (MindMed) Inc. 13G/A Amendment 2 MNMD · 60255C885	MNMD	60255C885	6.9%	5,500,000	13G/A Amendment 2	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			6.9%	5,500,000
Deep Track Biotechnology Master Fund, Ltd.			6.9%	5,500,000
David Kroin			6.9%	5,500,000
Jade Biosciences, Inc. 13G/A Amendment 1 JBIO · 008064206	JBIO	008064206	7.0%	2,279,892	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			7.0%	2,279,892
Deep Track Biotechnology Master Fund, Ltd.			7.0%	2,279,892
David Kroin			7.0%	2,279,892
Invivyd, Inc. 13G/A Amendment 3 IVVD · 00534A102	IVVD	00534A102	0%	0	13G/A Amendment 3	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Inovio Pharmaceuticals, Inc. 13G/A Amendment 1 INO · 45773H409	INO	45773H409	2.4%	1,314,796	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			2.4%	1,314,796
Deep Track Biotechnology Master Fund, Ltd.			2.4%	1,314,796
David Kroin			2.4%	1,314,796
Structure Therapeutics Inc. 13G/A Amendment 3 GPCR · 86366E106	GPCR	86366E106	7.3%	12,647,433	13G/A Amendment 3	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			7.3%	12,647,433
Deep Track Biotechnology Master Fund, Ltd.			7.3%	12,647,433
David Kroin			7.3%	12,647,433
89bio, Inc. 13G/A Amendment 2 ETNB · 282559103	ETNB	282559103	6.3%	9,356,171	13G/A Amendment 2	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			6.3%	9,356,171
Deep Track Biotechnology Master Fund, Ltd.			6.3%	9,356,171
David Kroin			6.3%	9,356,171
enGene Holdings Inc. 13G/A Amendment 2 ENGN · 29286M105	ENGN	29286M105	4.4%	2,239,353	13G/A Amendment 2	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			4.4%	2,239,353
Deep Track Biotechnology Master Fund, Ltd.			4.4%	2,239,353
David Kroin			4.4%	2,239,353
Dianthus Therapeutics Inc. 13G/A Amendment 1 DNTH · 252828108	DNTH	252828108	0%	0	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Avalo Therapeutics, Inc. 13G/A Amendment 1 AVTX · 05338F306	AVTX	05338F306	0%	0	13G/A Amendment 1	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Autolus Therapeutics plc 13G/A Amendment 4 AUTL · 05280R100	AUTL	05280R100	1.0%	2,568,613	13G/A Amendment 4	11/14/2025 Event 9/30/2025
Deep Track Capital, LP			1.0%	2,568,613
Deep Track Biotechnology Master Fund, Ltd.			1.0%	2,568,613
David Kroin			1.0%	2,568,613
MoonLake Immunotherapeutics 13G MLTX · 61559X104	MLTX	61559X104	6.5%	4,610,071	13G	11/12/2025 Event 11/5/2025
Deep Track Capital, LP			6.5%	4,610,071
Deep Track Biotechnology Master Fund, Ltd.			6.5%	4,610,071
David Kroin			6.5%	4,610,071
Cybin Inc. 13G HELP · 23256X407	HELP	23256X407	6.1%	3,072,250	13G	11/4/2025 Event 10/28/2025
Deep Track Capital, LP			6.1%	3,072,250
Deep Track Biotechnology Master Fund, Ltd.			6.1%	3,072,250
David Kroin			6.1%	3,072,250
Cybin Inc. 13G/A Amendment 1 HELP · 23256X407	HELP	23256X407	4.0%	1,000,000	13G/A Amendment 1	10/29/2025 Event 9/30/2025
Deep Track Capital, LP			4.0%	1,000,000
Deep Track Biotechnology Master Fund, Ltd.			4.0%	1,000,000
David Kroin			4.0%	1,000,000
Enanta Pharmaceuticals Inc 13G ENTA · 29251M106	ENTA	29251M106	5.3%	1,484,513	13G	10/9/2025 Event 10/2/2025
Deep Track Capital, LP			5.3%	1,484,513
Deep Track Biotechnology Master Fund, Ltd.			5.3%	1,484,513
David Kroin			5.3%	1,484,513
Palisade Bio, Inc. 13G PALI · 696389402	PALI	696389402	10.0%	10,012,958	13G	10/8/2025 Event 10/1/2025
Deep Track Capital, LP			10.0%	10,012,958
Deep Track Biotechnology Master Fund, Ltd.			6.5%	6,509,387
David Kroin			10.0%	10,012,958
Deep Track Special Opportunities Fund, LP.			3.5%	3,503,571
Akero Therapeutics, Inc. 13G AKRO · 00973Y108	AKRO	00973Y108	5.5%	4,400,000	13G	10/7/2025 Event 9/30/2025
Deep Track Capital, LP			5.5%	4,400,000
Deep Track Biotechnology Master Fund, Ltd.			5.5%	4,400,000
David Kroin			5.5%	4,400,000
LB Pharmaceuticals Inc 13D LBRX · 50180M108	LBRX	50180M108	14.9%	3,352,804	13D	9/19/2025 Event 9/12/2025
Deep Track Biotechnology Master Fund, Ltd.			12.0%	2,686,138
Deep Track Special Opportunities Fund, LP			3.0%	666,666
Deep Track Capital, LP			14.9%	3,352,804
David Kroin			14.9%	3,352,804
Dynavax Technologies Corporation 13G/A Amendment 2 DVAX · 268158201	DVAX	268158201	13.4%	15,726,349	13G/A Amendment 2	8/25/2025 Event 8/22/2025
Deep Track Biotechnology Master Fund, Ltd.			13.4%	15,726,349
Deep Track Capital, LP			13.4%	15,726,349
David Kroin			13.4%	15,726,349
X4 Pharmaceuticals, Inc. 13G XFOR · 98420X202	XFOR	98420X202	10.0%	2,366,995	13G	8/19/2025 Event 8/12/2025
Deep Track Capital, LP			10.0%	2,366,995
Deep Track Biotechnology Master Fund, Ltd.			10.0%	2,366,995
David Kroin			10.0%	2,366,995
Abivax SA 13G/A Amendment 2 ABVX · 00370M103	ABVX	00370M103	4.8%	3,480,144	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			4.8%	3,480,144
Deep Track Biotechnology Master Fund, Ltd.			4.8%	3,480,144
David Kroin			4.8%	3,480,144
Terns Pharmaceuticals, Inc. 13G/A Amendment 3 TERN · 880881107	TERN	880881107	8.6%	7,495,000	13G/A Amendment 3	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			8.6%	7,495,000
Deep Track Biotechnology Master Fund, Ltd.			8.6%	7,495,000
David Kroin			8.6%	7,495,000
ZURA Bio Ltd 13G/A Amendment 3 ZURA · G9TY5A101	ZURA	G9TY5A101	7.1%	4,616,514	13G/A Amendment 3	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			7.1%	4,616,514
Deep Track Biotechnology Master Fund, Ltd.			7.1%	4,616,514
David Kroin			7.1%	4,616,514
Regulus Therapeutics Inc. 13G/A Amendment 1 RGLS · 75915K309	RGLS	75915K309	0%	0	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Pliant Therapeutics, Inc. 13G/A Amendment 2 PLRX · 729139105	PLRX	729139105	6.4%	3,947,807	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			6.4%	3,947,807
Deep Track Biotechnology Master Fund, Ltd.			6.4%	3,947,807
David Kroin			6.4%	3,947,807
MBX Biosciences, Inc. 13G/A Amendment 1 MBX · 55287L101	MBX	55287L101	6.6%	2,188,592	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			6.6%	2,188,592
Deep Track Biotechnology Master Fund, Ltd.			6.6%	2,188,592
David Kroin			6.6%	2,188,592
Maze Therapeutics Inc. 13G/A Amendment 1 MAZE · 578784100	MAZE	578784100	9.0%	3,948,910	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			9.0%	3,948,910
Deep Track Biotechnology Master Fund, Ltd.			9.0%	3,948,910
David Kroin			9.0%	3,948,910
Korro Bio, Inc. 13G/A Amendment 2 KRRO · 500946108	KRRO	500946108	3.0%	277,966	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			3.0%	277,966
Deep Track Biotechnology Master Fund, Ltd.			3.0%	277,966
David Kroin			3.0%	277,966
Structure Therapeutics Inc. 13G/A Amendment 2 GPCR · 86366E106	GPCR	86366E106	8.9%	15,401,751	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			8.9%	15,401,751
Deep Track Biotechnology Master Fund, Ltd.			8.9%	15,401,751
David Kroin			8.9%	15,401,751
Geron Corp 13G/A Amendment 1 GERN · 374163103	GERN	374163103	6.8%	43,000,000	13G/A Amendment 1	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			6.8%	43,000,000
Deep Track Biotechnology Master Fund, Ltd.			6.8%	43,000,000
David Kroin			6.8%	43,000,000
Bicycle Therapeutics plc 13G/A Amendment 5 BCYC · 088786108	BCYC	088786108	2.4%	1,203,244	13G/A Amendment 5	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			2.4%	1,203,244
Deep Track Biotechnology Master Fund, Ltd.			2.4%	1,203,244
David Kroin			2.4%	1,203,244
Allakos Inc. 13G/A Amendment 2 ALLK · 01671P100	ALLK	01671P100	0%	0	13G/A Amendment 2	8/14/2025 Event 6/30/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Imagenebio, Inc. 13G IMA · 45175G207	IMA	45175G207	7.9%	878,516	13G	8/4/2025 Event 7/28/2025
Deep Track Capital, LP			7.9%	878,516
Deep Track Biotechnology Master Fund, Ltd.			7.9%	878,516
David Kroin			7.9%	878,516
Ikena Oncology, Inc. 13G/A Amendment 1 IKNA · 45175G108	IKNA	45175G108	0%	0	13G/A Amendment 1	8/4/2025 Event 7/28/2025
Deep Track Capital, LP			0%	0
Deep Track Biotechnology Master Fund, Ltd.			0%	0
David Kroin			0%	0
Tarsus Pharmaceuticals, Inc. 13G TARS · 87650L103	TARS	87650L103	5.6%	2,352,960	13G	7/28/2025 Event 7/21/2025
Deep Track Capital, LP			5.6%	2,352,960
Deep Track Biotechnology Master Fund, Ltd.			5.6%	2,352,960
David Kroin			5.6%	2,352,960
Jade Biosciences, Inc. 13G JBIO · 008064206	JBIO	008064206	8.6%	2,784,648	13G	6/20/2025 Event 4/28/2025
Deep Track Capital, LP			8.6%	2,784,648
Deep Track Biotechnology Master Fund, Ltd.			8.6%	2,784,648
David Kroin			8.6%	2,784,648